Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

HRMY Harmony Biosciences Holdings, Inc.

Post-Mkt 10-14 17:54:26 EDT

37.51

+0.48

+1.30%

盘后37.51

+0.000.00%

17:40 EDT

High38.31	Low36.92	Vol972.23K
Open37.16	D1 Closing37.03	Amplitude3.75%
Mkt Cap2.18B	Tradable Cap1.95B	Total Shares58.24M
T/O36.67M	T/O Rate1.87%	Tradable Shares52.10M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"HRMY","market":"US","secType":"STK","nameCN":"Harmony Biosciences Holdings, Inc.","latestPrice":37.51,"timestamp":1792008000000,"preClose":37.03,"halted":0,"volume":972227,"hourTrading":{"tag":"盘后","latestPrice":37.51,"preClose":37.51,"latestTime":"17:40 EDT","volume":72852,"amount":2732711.740512,"timestamp":1792014010101,"change":0,"changeRate":0,"amplitude":0.01253},"delay":0,"changeRate":0.012962462867944825,"floatShares":52095000,"shares":58236393,"eps":3.09102,"marketStatus":"Post-Mkt","change":0.48,"latestTime":"10-14 17:54:26 EDT","open":37.16,"high":38.31,"low":36.92,"amount":36670316.040858,"amplitude":0.037537,"askPrice":38.24,"askSize":52,"bidPrice":36.78,"bidSize":54,"shortable":3,"etf":0,"ttmEps":3.09102,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1792022400000},"marketStatusCode":4,"adr":0,"listingDate":1597809600000,"exchange":"NASDAQ","adjPreClose":37.03,"preHourTrading":{"tag":"盘前","latestPrice":37.5,"preClose":37.03,"latestTime":"07:04 EDT","volume":4,"amount":150,"timestamp":1791975873511,"change":0.47,"changeRate":0.012692,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.51,"preClose":37.51,"latestTime":"17:40 EDT","volume":72852,"amount":2732711.740512,"timestamp":1792014010101,"change":0,"changeRate":0,"amplitude":0.01253},"volumeRatio":1.088336,"impliedVol":0.2149,"impliedVolPercentile":0.0637},"requestUrl":"/m/hq/s/HRMY/wiki","defaultTab":"wiki","newsList":[{"id":"2674480535","title":"Mizuho positive on Harmony Biosciences CEO transition","url":"https://stock-news.laohu8.com/highlight/detail?id=2674480535","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674480535?lang=en_us&edition=fundamental","pubTime":"2026-10-12 22:20","pubTimestamp":1791814810,"startTime":"0","endTime":"0","summary":"After Harmony Biosciences (HRMY) announced that Peter Anastasiou, the company’s current COO, will become President, CEO and a board member, Mizuho ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mizuho-positive-on-harmony-biosciences-ceo-transition-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mizuho-positive-on-harmony-biosciences-ceo-transition-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674808002","title":"Harmony Biosciences Price Target Maintained with a $50.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2674808002","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674808002?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:37","pubTimestamp":1791812220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674811808","title":"US Stocks on the MOVE-Salesforce, Brown & Brown, IonQ, Harmony Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2674811808","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674811808?lang=en_us&edition=fundamental","pubTime":"2026-10-12 21:03","pubTimestamp":1791810185,"startTime":"0","endTime":"0","summary":"BUZZ-US STOCKS ON THE MOVE-Salesforce, Brown & Brown, IonQ, Harmony BiosciencesOct 12 (Reuters)-US stock indexes were on track for a muted open on Monday as investors watched oil prices and global eve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nL4N45Y0RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU0496365809.HKD","LU0310800965.SGD","LU2458330243.SGD","LU1316542783.SGD","LU0985481810.HKD","BK4588","LU1267930490.SGD","LU1496350502.SGD","IE00BKVL7J92.USD","IE00B19Z8X17.USD","LU1670710661.SGD","IONQ","BK4528","LU0477156797.USD","LU0878866978.SGD","LU0353189680.USD","LU2242646821.SGD","LU2361044865.SGD","LU0354030438.USD","LU1571399168.USD","LU0211326839.USD","LU0225771236.USD","LU0889566641.SGD","GDDY","LU0742534661.SGD","LU0557290698.USD","IE00B894F039.SGD","LU0456855351.SGD","ENVX","BK4527","LU1064131342.USD","LU2133065610.SGD","LU2491049909.HKD","BK4585","LU0109392836.USD","BK4516","LU1551013342.USD","BK4532","LU1201861249.SGD","LU0320765992.SGD","LU0267386448.USD","FTXH","LU2087625088.SGD","BK4602","LU0096364046.USD","LU2461242641.AUD","LU1868836591.USD","QTUP","IE00BJJMRZ35.SGD","LU1989764748.USD","LU0306807586.USD","LU0980610538.SGD","LU0052756011.USD","LU1868837136.USD","LU1720051108.HKD","LU2286300806.USD","BK4139","BRO","IE00BJTD4V19.USD","HRMY","LU0069063385.USD","LU0353189763.USD","LU1261432733.SGD","BK4124","LU1791710400.SGD","IRE","LU1951200564.SGD","IONZ","BKCH","LU0211328371.USD","LU0061475181.USD","LU0106261372.USD","LU0868494617.USD","LU0889565833.HKD","BK4173","BK4116","LU1804176565.USD","WGMI","LU0528227936.USD","LU1235294995.USD","LU0048573561.USD","LU0310799852.SGD","LU0648001328.SGD","LU1551013425.SGD","IOYY","LU1489326972.SGD","LU2596442595.SGD","LU0476273544.USD","LU1236620750.USD","BK4559","BK4607","IE0002141913.USD","IE00BQXX3C00.GBP","LU1548497426.USD","LU1720051017.SGD","LU0689626769.HKD","IE00B2B36J28.USD","LU0306806265.USD","LU1046421795.USD","LU1093756325.SGD","DAPP","BK4561","IE00B19Z8W00.USD","LU0719512351.SGD","STCE","LU0689472784.USD","LU2458330169.SGD","BK4600","LU0225284248.USD","LU2264538146.SGD","IE00BZ1G4Q59.USD","LU0130102774.USD","LU2491050154.USD","LU0976567544.SGD","LU2491050071.SGD","BK4096","IE00BFXG1179.USD","LU2361044949.HKD","LU0957808578.USD","LU1923623000.USD","BK4613","BK4598","LU0314104364.USD","LU1989764664.SGD","LU0472753341.HKD","LU1236620834.HKD","BIIB","LU2095319765.USD","BK4538","LU1201861165.SGD","LU1430594728.SGD","LU0511384066.AUD","LU0985489474.SGD","LU1880398471.USD","LU0444971666.USD","LU1814569148.SGD","IE00BQXX3D17.EUR","LU2108987350.USD","LU0157215616.USD","LU2357305700.SGD","BK4595","LU0433182093.SGD","LU1868837300.USD","LU0642271901.SGD","LU0820561909.HKD","LU1267930813.SGD","IREG","LU0109394709.USD","LU0127658192.USD","IONX","BK4141","LU0477156953.USD","LU2236285917.USD","TRAX","BK4567","IHE","LU2125154935.USD","IONL","LU1267930227.SGD","LU1815336760.USD","LU0444973449.USD","LU0130103400.USD","LU0237698245.USD","LU1496350171.SGD","IE00BJT1NW94.SGD","LU0198837287.USD","LU0792757196.USD","BK4550","LU1803068979.SGD","LU0124676726.USD","LU0130517989.USD","BK4170","LU2756315318.SGD","LU0082616367.USD","LU0211326755.USD","LU2242652126.USD","LU0251131958.USD","LU0354030511.USD","LU1868836914.USD","CRM","MNRS","LU2265009873.SGD","LU1718418525.SGD","LU1989771016.USD","BK4591","BK4581","LU1791710582.SGD","LU0234572021.USD","LU0057025933.USD","LU0321505868.SGD","BK4543","LU0251142724.SGD","IREN","LU2244417387.USD","LU1670710588.SGD","LU1093756168.USD","IE00BSNM7G36.USD","IE00B19Z9Z06.USD","BK4505","LU0432979614.USD","BK4535","LU0130518102.USD","FDIG","LU0238689110.USD","LU2210150020.SGD","BK4007","IE00B19Z9P08.USD","IE00BKPKM429.USD","LU0820562030.AUD","LU0321505439.SGD","LU1585245621.USD","CQTM","DCH","LU0211327993.USD","LU0234570918.USD","LU1883839398.USD","WQTM","LU1032466523.USD","IE00B19Z9505.USD","LU0006306889.USD","LU2756315664.SGD","LU0068578508.USD","BK4579","PBE","BK4548","IREC","LU1951198990.SGD","LU2247934214.USD","LU0289961442.SGD","BK4597","IREX","IE0008368304.USD","LU0889565916.HKD","IONC","IE00BQXX3F31.USD","LU1366333091.USD","LU0289739343.SGD","LU1642822529.SGD","LU1670711040.USD","LU2210149790.SGD","LU2361045086.USD","LU0114720955.EUR","LU0081259029.USD","LU0820561818.USD","IBLC","LU1074936037.SGD","LU1988902786.USD","LU1823568750.SGD","LU1323610961.USD","BK4533","BK4608","BMED","LU1983299246.USD","LU0187121727.USD","BMY","LU0128525689.USD","LU1670711123.USD","LU0882574055.USD","LU0943347566.SGD","LU2125154778.USD","IE00BJTD4N35.SGD","LU1291159041.SGD","IREZ","BITQ","LU1880398554.USD","LU0211331839.USD","BK4534","LU1868836757.USD","LU2360032135.SGD","LU0648000940.SGD","CRMG","IE00BFTCPJ56.SGD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674743858","title":"Harmony Biosciences Names COO Peter Anastasiou CEO Effective Jan. 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2674743858","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674743858?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:00","pubTimestamp":1791802858,"startTime":"0","endTime":"0","summary":"Harmony Biosciences names COO Peter Anastasiou CEO effective Jan. 1, 2027Harmony Biosciences named Peter Anastasiou as president, CEO, board member effective Jan. 1, 2027; he is senior EVP and COO.Ana","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nNDL9zQjP4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BN0W2V16.EUR","SG9999014021.USD","HRMY","BK4112","IE00BKPKM429.USD","IE00BQXX3D17.EUR","IE00B3QW5Z07.USD","SG9999014005.SGD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4585","IE00B64PRP62.GBP","LU0314104364.USD","LU2210150020.SGD","SG9999014013.SGD","IE00BQXX3C00.GBP","BCDF","IE00BN0W2T93.GBP","BK4007","IE00BQXX3F31.USD","BK4588","NDAQ","LU2210149790.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674874843","title":"Harmony Biosciences - Jeffrey M. Dayno to Retire as CEO and Step Down from Board at Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2674874843","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674874843?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:00","pubTimestamp":1791802800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUA2DGTHR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674874842","title":"Harmony Biosciences - Reiterates Full-Year 2026 Wakix Net Revenue Guidance of $1 Bln-$1.04 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2674874842","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674874842?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:00","pubTimestamp":1791802800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUA2DGTHR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674874810","title":"Harmony Biosciences - on Track to Report BP-205 Mad Study Data in Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2674874810","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674874810?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:00","pubTimestamp":1791802800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUA2DGTHR:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674841874","title":"Harmony Biosciences - Appoints Peter Anastasiou as President, CEO, and Board Member Effective Jan 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2674841874","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674841874?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:00","pubTimestamp":1791802800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261012:nTUA2DGTHR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674871041","title":"Press Release: Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2674871041","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674871041?lang=en_us&edition=fundamental","pubTime":"2026-10-12 19:00","pubTimestamp":1791802800,"startTime":"0","endTime":"0","summary":"The Board of Directors has appointed Peter Anastasiou, former Harmony board member and current Sr. EVP and COO, to become President, Chief Executive Officer and a member of the Board, effective Januar","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4022","BK4232","HRMY","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673067210","title":"Harmony BioSciences' Wakix Franchise, Pipeline Offer Multiple Value Drivers, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673067210","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673067210?lang=en_us&edition=fundamental","pubTime":"2026-10-08 23:45","pubTimestamp":1791474307,"startTime":"0","endTime":"0","summary":"Harmony BioSciences (HRMY) has several underappreciated value drivers supporting its long-term growth outlook, including its Wakix franchise, pitolisant lifecycle initiatives and BP-205 program, Oppen","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673067430","title":"Why Harmony Biosciences Holdings (HRMY) Is Getting Attention Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2673067430","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673067430?lang=en_us&edition=fundamental","pubTime":"2026-10-07 09:20","pubTimestamp":1791336013,"startTime":"0","endTime":"0","summary":"Phase 3 HBS-301 data in focus for Harmony Biosciences\nHarmony Biosciences Holdings (HRMY) is drawing attention after announcing plans to present new Phase 3 data for HBS-301 in narcolepsy and idiopathic hypersomnia at the European Narcolepsy Days meeting in Bern.\nAgainst this backdrop, Harmony Biosciences Holdings is trading at US$39.36, with mixed momentum as the 30-day share price return declined 6.84%, the 90-day move is up 3.36%, and the 1-year total shareholder return of 45.51% signals...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6121000-choice1-card/1788949577743"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/why-harmony-biosciences-holdings-hrmy-is-getting-attention-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-hrmy/harmony-biosciences-holdings/news/why-harmony-biosciences-holdings-hrmy-is-getting-attention-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672075409","title":"Harmony Biosciences Presents Phase 3 HBS-301 Trial Data in Narcolepsy, Idiopathic Hypersomnia at European Narcolepsy Days","url":"https://stock-news.laohu8.com/highlight/detail?id=2672075409","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672075409?lang=en_us&edition=fundamental","pubTime":"2026-10-01 20:05","pubTimestamp":1790856350,"startTime":"0","endTime":"0","summary":"Harmony Biosciences presents Phase 3 HBS-301 trial data in narcolepsy, idiopathic hypersomnia at European Narcolepsy DaysHarmony Biosciences set a poster presentation on Phase 3 trials of investigatio","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL29pHxG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112","BCDF","IE00BGHQF748.EUR","LU0314104364.USD","IE00BN0W2V16.EUR","BK4007","IE00BN0W2W23.USD","LU2095319765.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4585","HRMY","LU2210150020.SGD","SG9999014039.USD","SG9999014005.SGD","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672754856","title":"Deutsche Bank Lifts Price Target on Harmony Biosciences Holdings to $42 From $39, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2672754856","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672754856?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:37","pubTimestamp":1790854676,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings (HRMY) has an average rating of overweight and mean price target of $47.64, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic res","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HRMY","DB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670342945","title":"Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Biogen (BIIB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670342945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670342945?lang=en_us&edition=fundamental","pubTime":"2026-09-26 01:30","pubTimestamp":1790357441,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Harmony Biosciences Holdings (HRMY), BioNTech SE (BNTX) and Bioge...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-harmony-biosciences-holdings-hrmy-biontech-se-bntx-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-harmony-biosciences-holdings-hrmy-biontech-se-bntx-and-biogen-biib-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0441851309.USD","IE0034224299.USD","XLV","BK4566","PBE","LU0210637038.USD","LU2152927971.USD","LU0589944569.HKD","LU1861220207.SGD","LU0234570918.USD","LU0251143029.SGD","LU1242518857.USD","LU2065171402.SGD","LU0516423091.SGD","LU0516422440.USD","LU1839390173.USD","SE","SGXZ58947870.SGD","LU0109394709.USD","FDNI","BK4532","LU0261945553.USD","SG9999002620.SGD","XBI","LU0499858602.USD","IE00B19Z9P08.USD","LU0516422366.SGD","LU2125910849.SGD","LABU","IE0031814969.USD","SG9999013478.USD","BIIB","LU0128526141.USD","HRMY","LU2065169927.USD","BMED","LU0029874061.USD","LU0979878070.USD","LU2008162690.USD","LU2360107671.USD","SG9999002406.SGD","LU0264606111.USD","LU0889565916.HKD","LU0532188223.SGD","HCSG","BNTX","LU0737861269.HKD","LU1770036033.HKD","BK4548","IE00BD6J9T35.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669464161","title":"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Oruka Therapeutics (ORKA) and Harmony Biosciences Holdings (HRMY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669464161","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669464161?lang=en_us&edition=fundamental","pubTime":"2026-09-24 18:30","pubTimestamp":1790245831,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Praxis Precision Medicines (PRAX), Oruka Therapeutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-oruka-therapeutics-orka-and-harmony-biosciences-holdings-hrmy-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJJMRZ35.SGD","LU0128526141.USD","XBI","BK4581","PRAX","LU0109394709.USD","IE0009355771.USD","IE00B4R5TH58.HKD","ORKA","LABU","BK4007","BK4137","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IBRN","LU0320765992.SGD","BK4585","HRMY","IE0002141913.USD","XLV","LU0889565916.HKD","HCSG","BK4139","LU0029874061.USD","BK4588","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668197378","title":"Harmony Biosciences CMO Budur Kumar Disposes of USD 1,656,098.48 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2668197378","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668197378?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:48","pubTimestamp":1789764531,"startTime":"0","endTime":"0","summary":"Harmony Biosciences CMO Budur Kumar disposes of USD 1,656,098.48 in common sharesHarmony Biosciences Chief Medical Officer Budur Kumar sold 38,452 shares on Sept. 16-18 at about $43 per share.He exerc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL8YQQGd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Harmony Biosciences CMO Budur Kumar Disposes of USD 1,656,098.48 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666755887","title":"Harmony Biosciences CMO Budur Kumar Disposes of USD 1.43 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666755887","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666755887?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:13","pubTimestamp":1788988408,"startTime":"0","endTime":"0","summary":"Harmony Biosciences CMO Budur Kumar disposes of USD 1.43 million in common sharesHarmony Biosciences Chief Medical Officer Budur Kumar cut his stake to 13,115 common shares in transactions dated Sept.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL7X2TNf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Harmony Biosciences CMO Budur Kumar Disposes of USD 1.43 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","HRMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662694702","title":"Harmony Biosciences to Join Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2662694702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662694702?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:05","pubTimestamp":1787832342,"startTime":"0","endTime":"0","summary":"Harmony Biosciences to join Cantor Global Healthcare Conference fireside chatHarmony Biosciences management to join a fireside chat at the 2026 Cantor Global Healthcare Conference on Sept. 10, 2026.Se","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL2Q63lR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BGHQF748.EUR","SG9999014021.USD","NDAQ","BK4007","LU0314104364.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","LU2210150020.SGD","BCDF","LU2095319765.USD","SG9999014005.SGD","BK4585","IE00BQXX3C00.GBP","SG9999014013.SGD","SG9999014039.USD","HRMY","BK4112","IE00BKPKM429.USD","LU2210149790.SGD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662716423","title":"Harmony Biosciences Price Target Announced at $60.00/Share by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2662716423","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662716423?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:00","pubTimestamp":1787745600,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/HRMY/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658764239","title":"Harmony Biosciences: Strengthening Core Business and Pipeline Support Unchanged $55 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2658764239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658764239?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:15","pubTimestamp":1786529746,"startTime":"0","endTime":"0","summary":"Harmony Biosciences Holdings, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Patrick Trucchio from H.C. Wainw...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/harmony-biosciences-strengthening-core-business-and-pipeline-support-unchanged-55-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/harmony-biosciences-strengthening-core-business-and-pipeline-support-unchanged-55-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4585","XBI","BK4588","LABU","XLV","BK4581","HRMY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.harmonybiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0592},{"period":"1month","weight":-0.1081},{"period":"3month","weight":0.061},{"period":"6month","weight":0.2587},{"period":"1year","weight":0.4048},{"period":"ytd","weight":-0.0104}],"compareEarnings":[{"period":"1week","weight":-0.0014},{"period":"1month","weight":0.018},{"period":"3month","weight":0.0307},{"period":"6month","weight":0.1088},{"period":"1year","weight":0.1734},{"period":"ytd","weight":0.1409}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.035612},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.051691},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.016911},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.04592},{"month":5,"riseRate":0.666667,"avgChangeRate":0.043963},{"month":6,"riseRate":0.666667,"avgChangeRate":0.019037},{"month":7,"riseRate":0.666667,"avgChangeRate":0.02924},{"month":8,"riseRate":0.833333,"avgChangeRate":0.069105},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.020497},{"month":10,"riseRate":0.571429,"avgChangeRate":-0.013582},{"month":11,"riseRate":0.833333,"avgChangeRate":0.105341},{"month":12,"riseRate":0.5,"avgChangeRate":0.02881}],"exchange":"NASDAQ","name":"Harmony Biosciences Holdings, Inc.","nameEN":"Harmony Biosciences Holdings, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Harmony Biosciences Holdings, Inc.,HRMY,Harmony Biosciences Holdings, Inc.股票,Harmony Biosciences Holdings, Inc.股票老虎,Harmony Biosciences Holdings, Inc.股票老虎国际,Harmony Biosciences Holdings, Inc.行情,Harmony Biosciences Holdings, Inc.股票行情,Harmony Biosciences Holdings, Inc.股价,Harmony Biosciences Holdings, Inc.股市,Harmony Biosciences Holdings, Inc.股票价格,Harmony Biosciences Holdings, Inc.股票交易,Harmony Biosciences Holdings, Inc.股票购买,Harmony Biosciences Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Harmony Biosciences Holdings, Inc.(HRMY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Harmony Biosciences Holdings, Inc.(HRMY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}